CAMP -
CAMP4 Therapeutics Corporation Common Stock
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| 3.55 -0.64 (-18.03%) |
--- |
--- |
-0.08 (-2.68%) |
--- |
-0.64 (-18.03%) |
--- |
--- |
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.
Earnings & Ratios
- Basic EPS:
- -0.62
- Diluted EPS:
- -0.62
- Basic P/E:
- -4.6935
- Diluted P/E:
- -4.6935
- RSI(14) 1m:
- 10.0
- VWAP:
- 2.91
- RVol:
Events
| Period |
Kind |
Movement |
Occurred At |
Related News
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
Sep 10, 2025 11:00
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting
May 16, 2025 10:00
Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
May 06, 2025 17:00
CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference
Dec 02, 2024 13:00
CalAmp Reaches Comprehensive Agreement to Significantly Reduce Debt, Go Private, and Strengthen Financial Flexibility to Support Innovation Through a Consensual Financial Restructuring
Jun 03, 2024 13:25
American Superconductor (AMSC) Q4 Earnings and Revenues Surpass Estimates
May 29, 2024 21:35
Ballard Power Systems (BLDP) Reports Q1 Loss, Misses Revenue Estimates
May 07, 2024 13:45
CalAmp Enhances School Bus Solutions Suite with Dispatch Monitor
May 01, 2024 20:35
Top 3 Tech Stocks That Could Lead To Your Biggest Gains In March
Mar 21, 2024 10:50
CalAmp Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Feb 28, 2024 02:22